[
1. Blobel G (2000) Protein targeting. Biosci Rep 20:303-344. doi: 10.1023/a:101031883260410.1023/A:1010318832604
]Search in Google Scholar
[
2. Cecconi A, Vilchez-Tschischke JP, Mateo J, Sanchez Gonzalez J, España S, et al. (2021) Effects of colchicine on atherosclerotic plaque stabilization: a multimodality imaging study in an animal model. J Cardiovasc Transl Res 14(1):150-160. doi:10.1007/s12265-020-09974-710.1007/s12265-020-09974-7
]Search in Google Scholar
[
3. Chaldakov GN and Nikolov SD (1975) Ultrastructure of the arterial smooth muscle cell. In: Wolf S, Werthessen NT, editors. The Smooth Muscle of the Artery. New York City, NY: Plenum Press. Adv Exp Med Biol 57:14-20.
]Search in Google Scholar
[
4. Chaldakov GN, Nikolov S, Vancov V (1977) Fine morphological aspects of the secretory process in arterial smooth muscle cells. II. Role of microtubules. Acta Morphol Acad Sci Hung 25:167-174.
]Search in Google Scholar
[
5. Chaldakov GN and Kádár A (1978) Microtubules in arterial smooth muscle cells in vivo and in tissue culture. An electron microscope study. In: W. Hauss, R. Wissler, R. Lehman, editors. State of Prevention and Therapy of Human Arteriosclerosis and in Animal Models. Rheinisch-Westfalische Akad. Der Wissenschaften, p. 211-231.
]Search in Google Scholar
[
6. Chaldakov G (2016) GEORGE E. PALADE LECTURE. Human body as a multicrine system, with special reference to cell protein secretion: from vascular smooth muscles to adipose tissue. Adipobiology 8:6-18. doi: 10.14748/adipo.v8.208910.14748/adipo.v8.2089
]Search in Google Scholar
[
7. Chaldakov G, Stankulov I, Hristova M, Ghenev P (2003) Adipobiology of disease: Adipokines and adipokine-targeted pharmacology. Curr Pharm Des 9: 1023-1031. doi: 10.2174/138161203345515210.2174/1381612033455152
]Search in Google Scholar
[
8. Chaldakov GN (1982) Antitubulins - a new therapeutic approach for atherosclerosis? Atherosclerosis 44:385-390. doi: 10.1016/0021-9150(82)90013-210.1016/0021-9150(82)90013-2
]Search in Google Scholar
[
9. Chaldakov GN (2018) Colchicine, a microtubule-disassembling drug, in the therapy of cardiovascular diseases. Cell Biol Int 42:1079-1084. doi: 10.1002/cbin.1098810.1002/cbin.10988
]Search in Google Scholar
[
10. Chaldakov GN, Beltowsky J, Ghenev PI, Fiore M, Panayotov P, Rančič G, Aloe L (2012) Adipoparacrinology - vascular periadventitial adipose tissue (tunica adiposa) as an example. Cell Biol Int 36:327-330. doi: 10.1042/cbi2011042210.1042/CBI20110422
]Search in Google Scholar
[
11. Chaldakov GN and Fiore M (2010) Human body as a multicrine gland. Adipobiology 2: 73-75. doi: 10.14748/adipo.v2.26310.14748/adipo.v2.263
]Search in Google Scholar
[
12. Chaldakov GN and Vankov VN (1986a) Morphological aspects of secretion in the arterial smooth muscle cell, with special reference to the golgi complex and microtubular cytoskeleton. Atherosclerosis 61: 175-192. doi: 10.1016/0021-9150(86)90137-110.1016/0021-9150(86)90137-1
]Search in Google Scholar
[
13. Chaldakov GN and Vankov VN (1986b) Antifibrotic approach in the therapy of arterial occlusive diseases: new considerations. In: G. Trubestein, editor. Conservative Therapy of Arterial Occlusive Disease. Stuttgart, New York, Georg Thieme Verlag, p. 224-226
]Search in Google Scholar
[
14. Chaldakov GN, Zhelyazkova-Savova MD, Panayotova D, Fiore M, Yanev S (2020) Phenotypic modulation of smooth muscle cells and matrix metalloproteinases as targets for atherosclerotic plaque stabilization. Biomed Rev 31: 49-60. doi: 10.14748/bmr.v31.770410.14748/bmr.v31.7704
]Search in Google Scholar
[
15. Chaldakov GN (2021) Principles of Cell and Tissue Biology (in press).
]Search in Google Scholar
[
16. Farquhar MG (2012) A Man for all seasons: Reflections on the life and legacy of George Palade. Ann Rev Cell Dev Biol 28: 1-28. doi: 10.1146/annurev-cellbio-101011-15581310.1146/annurev-cellbio-101011-155813
]Search in Google Scholar
[
17. Farquhar MG and Palade GE (1998) The Golgi apparatus: 100 years of progress and controversy. Trends Cell Biol 8:2-10. doi: 10.1016/S0962-8924(97)01187-210.1016/S0962-8924(97)01187-2
]Search in Google Scholar
[
18. Frohlich J, Chaldakov GN, Vinciguerra M (2021) Cardio- and neurometabolic adipobiology: Consequences and implications for therapy. Int J Mol Sci 22: 4137. doi: 10.3390/ijms2208413710.3390/ijms22084137
]Search in Google Scholar
[
19. Ghenev PI, Aloe L, Kisheva AR, Singh M, Panayotov P, Fiore M, et al. (2017) QUO VADIS, ATHEROGENESIS? Part 1. Smooth muscle cell secretion – how foe becomes friend in the fight against the atherosclerotic plaque. Biomed Rev 28:134-138.10.14748/bmr.v28.4460
]Search in Google Scholar
[
20. Haust MD, More RH, Movat HZ (1960) The role of smooth muscle cells in the fibrogenesis of arteriosclerosis. Am J Pathol 37:377-389.
]Search in Google Scholar
[
21. Jena BP (2010) Porosome: the universal secretory portal in cells. Biomed Rev 21: 1-15. doi: 10.14748/bmr.v21.4210.14748/bmr.v21.42
]Search in Google Scholar
[
22. Lai CP and Breakefield XO (2012) Role of exosomes/microvesicles in the nervous system and use in emerging therapies. Front Physiol 3: 228. doi: 10.3389/fphys.2012.0022810.3389/fphys.2012.00228
]Search in Google Scholar
[
23. Lee JZ, Singh N, Howe CL, Low S-W, Huang JJ, Ortega G, et al. (2016) Colchicine for prevention of post-operative atrial fibrillation. A meta-analysis. J Am Coll Cardiol Clin Electrophyisol 2(1): 78-85. doi: https://doi.org/10.1016/j.jacep.2015.09.01610.1016/j.jacep.2015.09.016
]Search in Google Scholar
[
24. Libby P (2021) Inflammation in atherosclerosis - No longer a theory. Clin Chem 67:131-142. doi:10.1093/clinchem/hvaa27510.1093/clinchem/hvaa275
]Search in Google Scholar
[
25. Mazzarello P, Garbarino C, Calligaro A (2009) How Camillo Golgi became “the Golgi”. FEBS Lett 583: 3732-3737. doi: 10.1016/j.febslet.2009.10.01810.1016/j.febslet.2009.10.018
]Search in Google Scholar
[
26. Mullen M, Jin XY, Child A, Stuart AG, Dodd M, Aragon-Martin JA, et al. (2019) Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial. Lancet 394: 2263–2270. doi: 10.1016/S0140-6736(19)32518-810.1016/S0140-6736(19)32518-8
]Search in Google Scholar
[
27. Nickel W (2010) Pathways of unconventional protein secretion. Curr Opin Biotechnol 21: 621-626. doi: 10.1016/j.copbio.2010.06.00410.1016/j.copbio.2010.06.00420637599
]Search in Google Scholar
[
28. Nidorf SM, Eikelboom JW, Budgeon CA, Thompson PL (2013) Low-dose colchicine for secondary prevention of cardiovascular disease. J Am Coll Cardiol 61(4):404-410. doi: 10.1016/j.jacc.2012.10.02
]Search in Google Scholar
[
29. Palade G (1975) Intracellular aspects of the process of protein synthesis. Science 189: 347-358. doi: 10.1126/science.109630310.1126/science.10963031096303
]Search in Google Scholar
[
30. Palade GE (1971) Albert Claude and the beginnings of biological electron microscopy. J Cell Biol 50: 5d-19d. doi: 10.1083/jcb.50.1.5d10.1083/jcb.50.1.5d
]Search in Google Scholar
[
31. Ross R (1999) Atherosclerosis - An inflammatory disease. N Engl J Med 340: 115-126. doi: 10.1056/nejm19990114340020710.1056/NEJM1999011434002079887164
]Search in Google Scholar
[
32. Sadallah S, Eken C, Martin PJ, Schifferli JA (2011) Microparticles (ectosomes) shed by stored human platelets downregulate macrophages and modify the development of dendritic cells. J Immunol 186: 6543-6552. doi: 10.4049/jimmunol.100278810.4049/jimmunol.100278821525379
]Search in Google Scholar
[
33. Shankman LS, Gomez D, Cherepanova OA, Salmon M, Alencar GF, Haskins RM, et al. (2015) KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis. Nat Med 21(6): 628-637. doi: 10.1038/nm.386610.1038/nm.3866455208525985364
]Search in Google Scholar
[
34. Silver R and Pappas G (2005) Secretion without membrane fusion: Porocytosis. Anat Rec B New Anat 282: 18-37. doi: 10.1002/ar.b.2005010.1002/ar.b.2005015672353
]Search in Google Scholar
[
35. Singer MV (2003) Legacy of a distinguished scientist: George E. Palade. Pancreatology 3:518–519. doi: 10.1159/00007632810.1159/00007632814730177
]Search in Google Scholar
[
36. Tardif J-C, Kouz S, Waters DD, Bertrand OF, Diaz R, Maggioni AP, et al. (2019) Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med 381(26):2497-2505. doi: 10.1056/NEJMoa191238810.1056/NEJMoa191238831733140
]Search in Google Scholar
[
37. Töre F, Tonchev A, Fiore M, Tunçel N, Atanassova P, Aloe L, et al. (2007) From adipose tissue protein secretion to adipopharmacology of disease. Immun Endoc Metab Agents Med Chem 7: 149-155. doi: 10.2174/18715220778036371210.2174/187152207780363712
]Search in Google Scholar
[
38. Vaidya K, Arnott C, Martínez GJ, Ng B, McCormack S, Sullivan DR, et al. (2017) Colchicine therapy and plaque stabilization in patients with acute coronary syndrome. J Am Coll Cardiol Img. doi: https://doi.org/10.1016/j.jcmg.2017.08.01310.1016/j.jcmg.2017.08.01329055633
]Search in Google Scholar
[
39. Wirka RC, Wagh DA, Paik DT, et al. (2019) Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis. Nat Med 25(8): doi:10.1038/s41591-019-0512-510.1038/s41591-019-0512-5727419831359001
]Search in Google Scholar
[
40. Xiong W, Knispel RA, Dietz HC, Ramirez F, Baxter BT (2008) Doxycycline delays aneurysm rupture in a mouse model of Marfan syndrome. J Vasc Surg 47(1): 166-172. doi:10.1016/j.jvs.2007.09.01610.1016/j.jvs.2007.09.016414804618178469
]Search in Google Scholar
[
41. Yanev S, Fiore M, Hinev A, Ghenev PI, Hristova MG, Panayotov P, et al. (2016) From antitubulins to trackins. Biomed Rev 27:59-67.10.14748/bmr.v27.2112
]Search in Google Scholar
[
42. Zar M, Amadio P, Campodonico J, et al. (2020) Exosomes in cardiovascular diseases. Diagnostics 10:943. doi:10.3390/diagnostics1011094
]Search in Google Scholar